Βιβλιογραφία
- COVID-19 vaccines and kidney disease
- COVID-19- associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup (NATURE REVIEWS | NEPHROLOGY, CONSENSUS Statement, volume 16 | December 2020)
- Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 (Clinica Chimica Acta 509 (2020) 220–223, doi.org: 10.1016/j.cca.2020.06.026)
- Perspective Piece All together to Fight COVID-19 (Am. J. Trop. Med. Hyg., 102(6), 2020, pp. 1181–1183, doi:10.4269/ajtmh.20-0281)
- Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy (JAMA Network Open. 2021;4(2):e2037060. doi:10.1001/jamanetworkopen.2020.37060)
- COVID-19 and the Kidney Community: Coalescing in Crisis (Adv Chronic Kidney Dis. 2020;27(5):362-364, doi: 10.1053/j.ackd.2020.10.001)
- Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More (JAMA Published online February 10, 2021)
- Researchers Investigate What COVID-19 Does to the Heart (JAMA Published online February 10, 2021)
- COVID-19 Vaccination in Pregnant and Lactating Women (JAMA Published online February 8, 2021)
- Effectiveness of MaskWearing to Control Community Spread of SARS-CoV-2 (JAMA Published online February 10, 2021)
- Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection (JAMA Published online January 26, 2021)
- Necessity of 2 Doses of the Pfizer andModerna COVID-19 Vaccines (JAMA Published online February 3, 2021)
- Monoclonal Antibodies for COVID-19 (JAMA Published online February 5, 2021)
- Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19. A Randomized Clinical Trial (JAMA. 2021;325(3):254-264. doi:10.1001/jama.2020.25864)
- A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events (JAMA Published online February 5, 2021)
- SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants (JAMA Published online January 28, 2021)
- Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk (JAMA January 26, 2021 Volume 325, Number 4)
- Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 (JAMA Published online February 12, 2021)
- Emergence of a Novel SARS-CoV-2 Variant in Southern California (JAMA Published online February 11, 2021)
- Outpatient Dietary Management of Electrolyte Disorders During COVID-19 (JAMA Internal Medicine Published online February 8, 2021)
- SARS-CoV-2 Transmission From People Without COVID-19 Symptoms (JAMA Network Open. 2021;4(1):e2035057. doi:10.1001/jamanetworkopen.2020.35057)
- Food as medicine: A possible preventive measure against coronavirus disease (COVID-19) (Phytotherapy Research. 2020;34:3124–3136)
- Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection. The COVID A to Z Randomized Clinical Trial (JAMA Network Open. 2021;4(2):e210369. doi:10.1001/jamanetworkopen.2021.0369)
- Estimation of US Children’s Educational Attainment and Years of Life Lost Associated With Primary School Closures During the Coronavirus Disease 2019 Pandemic (JAMA Network Open. 2020;3(11):e2028786. doi:10.1001/jamanetworkopen.2020.28786)
- COVID-19 and mRNA Vaccines—First Large Test for a NewApproach (JAMA September 22/29, 2020 Volume 324, Number 12)
- Relationships Between AcademicMedicine Leaders and Industry—Time for Another Look? (JAMA November 10, 2020 Volume 324, Number 18)
- Therapy for Early COVID-19 A Critical Need (JAMA Published online November 11, 2020)
- Risk of COVID-19 During Air Travel (JAMA November 3, 2020 Volume 324, Number 17)
- COVID-19 Infection—Preventing Clinical Deterioration (JAMA Published online November 12, 2020)
- COVID-19 of dialysis patients in Japan: current status and guidance on preventive measures
- Coronavirus Disease 2019 (COVID-19) and Dialysis: The Experience in Singapore
- Managing the COVID-19 pandemic: international comparisons in dialysis patients
- Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea
- COVID-19 and the Kidney: From Epidemiology to Clinical Practice
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review
- Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea
- A brand-new cardiorenal syndrome in the COVID-19 setting
- Kidney disease and electrolytes in COVID-19: more than meets the eye
- Epidemiology of COVID-19 in an Urban Dialysis Center
- Maintenance Hemodialysis and COVID-19: Saving Lives With Caution, Care, and Courage
- Coronavirus disease 2019 in chronic kidney disease
- Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
- The clinical characteristics of coronavirus-associated nephropathy
- First considerations on the SARS‑CoV‑2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes
- Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID‑19 pandemic: survey of the Italian Society of Nephrology
- Serosurveillance and the COVID-19 Epidemic in the US Undetected, Uncertain, and Out of Control
- Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities
- A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece
- Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities
- COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
- The psychological impact of quarantine and how to reduce it: rapid review of the evidence
- COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
- Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health CareWorkers
- Minimizing the risk of COVID-19 among patients on dialysis
- COVID-19 Town Hall WEBINAR Registration Detail
- Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
- PRESYMPTOMATIC TRASMISSION OF SARS- COV2
- HD PTS WITH COVID-19
- COVID experience in Lombardy, Italy
- Management of kidney transplant immunosuppression LaPaz
- ERA-EDTA sharing Milano experience on coronavirus management in dialysis centers
- DIALYSIS COVID 2019 (Update)
- Dialysis Facilities Brace for COVID-19 – Renal and Urology News
- ERA-EDTA news and informations
- CDC
- 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China
- Άρθρο NDT για την μείωση της διασποράς του COVID – 19 στην αιμοκάθαρση από το EUDIAL Working Group of ERA-EDTA
- Watch the COVID-19 Organ Donation and Transplant Town Hall
- WEBINAR «Infection Prevention and Control in the time of Covid-19».
- Your invitation to the COVID-19 Town Hall Webinar